Safety and Tolerability of SYNB1020-CP-001

NCT03179878 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Urea Cycle Disorder

Interventions

DRUG: Placebo
DRUG: SYNB1020

Sponsor

Synlogic